A company developing personal cancer therapies that genetically engineer a patient’s immune system cells is being acquired in a deal valued at $11.9 billion. . . . → Read More: Engineered T-Cell Company Acquired for $11.9 Billion
|
|||||
|
|
 One comment - (Comments are closed)  Finance  biomedical, biotechnology, cancer, clinical trials, entrepreneurs, equity, investment, licensing, life sciences, merger, NIH, pharmaceuticals A new company is being established to provide genomics analysis systems for law enforcement, spun-off from a leading maker of genomics systems. . . . → Read More: Forensic Genomics Company Spun-Off From Illumina Comments are closed Joint ventures/collaborations biotechnology, entrepreneurs, genomics, life sciences, medical device, software, venture capital A team from three universities is developing in the lab synthetic islet cells, the cells that produce insulin in the pancreas, for eventual transplantation in people with type 1 diabetes. . . . → Read More: Engineered Insulin-Producing Cells to Be Grown in Lab Comments are closed Finance, New products biomedical, biotechnology, engineering, grant, life sciences, NSF, pharmaceuticals, preclinical, stem cells, university Researchers studying the immune system as a weapon against opioid addiction say they can develop vaccines that block combinations of opioids, like those sold on the street. . . . → Read More: Vaccines in Development for Opioid Combinations Comments are closed New products biomedical, biotechnology, chemistry, life sciences, pharmaceuticals, physical sciences, preclinical, university Global drug maker AstraZeneca is acquiring an option to license the rights to a technology based on genetic material transcribed from DNA, for new respiratory disease treatments. . . . → Read More: AstraZeneca, Biotech Partner on Messenger RNA Therapies Comments are closed Intellectual property, Joint ventures/collaborations biomedical, biotechnology, Europe, genomics, licensing, life sciences, pharmaceuticals, U.K. A clinical trial is underway testing a genetically engineered virus to kill cancer cells, then stimulate the immune system to treat solid tumor cancers. . . . → Read More: Trial Testing Engineered Virus as Cancer Treatment One comment - (Comments are closed) New products biomedical, biotechnology, cancer, clinical trials, entrepreneurs, genomics, life sciences, pharmaceuticals Researchers in the U.S., Denmark, and China devised a process with genome editing to remove viruses that prevent organs from pigs from being used for human transplants. . . . → Read More: Viruses Removed from Pig Organs for Human Transplants Comments are closed New products Asia, biomedical, biotechnology, China, entrepreneurs, Europe, genomics, life sciences, medical device, pharmaceuticals, university Skin grafts derived from genetically edited stem cells were shown in tests with lab mice to reduce glucose levels and weight gain that result from a high-fat diet. . . . → Read More: Gene-Edited Skin Grafts Shown to Control Glucose Levels 2 comments - (Comments are closed) New products biomedical, biotechnology, genomics, life sciences, medical device, pharmaceuticals, preclinical, stem cells, university A biotechnology company designing treatments with gene edits and transfers using benign viruses is raising $83.5 million in its second venture funding round. . . . → Read More: Gene Editing, Therapy Company Gains $83.5M in Venture Funds Comments are closed Finance biomedical, biotechnology, entrepreneurs, equity, genomics, investment, licensing, life sciences, pharmaceuticals, preclinical, university, venture capital A research study funded by the U.S. Department of Defense is investigating genetic alterations of plant viruses for delivery of genes to quickly protect corn crops against threats like pests and drought. . . . → Read More: Engineered Viruses Studied to Improve Plant Traits. One comment - (Comments are closed) Finance, New products agriculture, biotechnology, DoD, genomics, grant, life sciences, university |
A Thinking Person’s Artificial Intelligence Do You Want Your Bacon CRISPR? Health Care, Precisely One Person at a Time Let Guinea Pigs be Guinea Pigs Look Out Pharma. The Tech Industry is After You |
|||
|
Copyright © 2017 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
